SIA
NXTM

Sit Investment Associates’s NxStage Medical Inc. NXTM Stock Holding History

Sit Investment Associates’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-48,000
Closed -$1.2M – 684
2017
Q2 		$1.2M Buy
48,000
+10,550
+28% +$261K 0.03% 334
2017
Q1 		$1M Buy
37,450
+8,450
+29% +$233K 0.03% 356
2016
Q4 		$760K Buy
29,000
+11,400
+65% +$282K 0.02% 357
2016
Q3 		$440K Buy
+17,600
New +$410K 0.01% 356

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sit Investment Associates's NXTM Position: Q3 2017 in Review

Sit Investment Associates sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 48,000 shares — an estimated $1.2M sold.

Sit Investment Associates first reported a position in NXTM in Q3 2016 and held it in 4 quarters. The position peaked at $1.2M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Sit Investment Associates reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Sit Investment Associates sold 48,000 NxStage Medical Inc. shares in Q3 2017, an estimated $1.2M.
  • Sit Investment Associates first reported a position in NxStage Medical Inc. in Q3 2016 and held it in 4 quarters.
  • Sit Investment Associates's NxStage Medical Inc. position peaked at $1.2M in Q2 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Sit Investment Associates's 13F filing for Q3 2017, filed 18 Oct 2017.